trending Market Intelligence /marketintelligence/en/news-insights/trending/pCk4vDSE2VvGZjOv7ZVjIA2 content
Log in to other products

Login to Market Intelligence Platform

 /


Looking for more?

Contact Us
In This List

Zosano appoints board member

COVID-19 Pandemic Likely To Cause US Telemedicine Boom

Gauging Supply Chain Risk In Volatile Times

S&P Global Market Intelligence

Cannabis: Hashing Out a Budding Industry

Segment

IFRS 9 Impairment How It Impacts Your Corporation And How We Can Help


Zosano appoints board member

Zosano Pharma Corp. appointed Kenneth Greathouse to its board of directors.

Greathouse is the co-founder and has served as CEO of Manchester Pharmaceuticals, which was sold to Retrophin Inc. in 2014.